JANE STREET GROUP, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68,595
+31.3%
60,171
+5.4%
0.00%
Q2 2023$52,257
+101.9%
57,111
+23.6%
0.00%
Q1 2023$25,886
-91.4%
46,193
-91.2%
0.00%
Q4 2022$302,176
+9972.5%
523,703
+4822.5%
0.00%
Q3 2022$3,000
-94.7%
10,639
-93.4%
0.00%
Q2 2022$57,000
-90.9%
162,166
-81.4%
0.00%
Q1 2022$626,000
-17.1%
872,447
+161.1%
0.00%
Q4 2021$755,000
-8.9%
334,202
+16.0%
0.00%
Q3 2021$829,000
-5.6%
288,165
+24.3%
0.00%
Q2 2021$878,000
+102.8%
231,799
+81.2%
0.00%
Q1 2021$433,000
-6.1%
127,959
-22.4%
0.00%
Q4 2020$461,000
-13.5%
164,842
-22.4%
0.00%
Q3 2020$533,000
+6.4%
212,421
+475.5%
0.00%
Q2 2020$501,000
+324.6%
36,913
+137.8%
0.00%
Q1 2020$118,000
+66.2%
15,523
+38.1%
0.00%
Q4 2019$71,000
-43.7%
11,243
-65.1%
0.00%
Q3 2019$126,000
-77.8%
32,196
-72.5%
0.00%
-100.0%
Q2 2019$567,000
+894.7%
117,187
+1041.3%
0.00%
Q4 2018$57,000
-40.6%
10,268
+2.4%
0.00%
Q1 2018$96,000
-74.5%
10,024
-61.7%
0.00%
-100.0%
Q2 2017$376,000
+210.7%
26,186
+95.3%
0.00%0.0%
Q1 2016$121,000
-9.0%
13,410
+3.8%
0.00%0.0%
Q2 2015$133,000
-56.5%
12,915
+17.4%
0.00%
-75.0%
Q2 2014$306,00011,0000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders